EMC China Lab

Medical Device Packaging Biocompatibility

Views :
Update time : 2025-03-18

For medical devices that come into direct contact with patients, packaging is particULarly crucial. In particular, the biocompatibility of medical device packaging materials directly affects patient health and safety. Therefore, testing various indicators of medical device packaging materials is essential, especially biocompatibility testing.

 

Medical Device Packaging Biocompatibility(图1)


Biocompatibility Requirements for Medical Packaging Materials

The latest ISO 10993-1 standard mentions that packaging materials in contact with the product must be included in the evaluation process. This requirement arises because medical devices are often in prolonged contact with packaging materials, raising concerns about potential extractables and leachables transferring to the device. As a result, cheMICal analysis of packaging materials is necessary for evaluation.

 

Additionally, packaging materials that directly contact medical devices must undergo a biological safety assessment. Relevant guidelines can be found in ASTM F2475-20. Furthermore, if the medical device is used for pharmaceutical packaging, compliance with USP <87> Biological Reactivity Tests, in vitro and USP <88> Biological Reactivity Tests, in vivo is requiRED. These tests classify materials into Class I–IV based on invasiveness or implantability, ensuring material safety and reducing overall product risk. Moreover, the cleanliness of packaging materials is closely related to product cleanliness, making particulate residue a critical factor for consideration.

 

Potential Risks of Non-Compliant Packaging Materials

If non-compliant medical device packaging materials come into short-term contact with the human body, they may cause toxicity, irritation, teratogenicity, and localized inflammation at both the cellular and systemic levels. Long-term exposure may lead to genetic mutations, teratogenic effects, or even carcinogenicity. When in contact with blood, such materials could cause coagulation abnormalities and hemolysis.

 

Therefore, all materials used in medical device packaging must undergo biocompatibility testing. China JJR Laboratory is certified to conduct biocompatibility testing and biological evaluations for medical device packaging materials, including toxicological assessments. We welcome inquiries regarding our services.


Email:hello@jjrlab.com


Leave Your Message


Write your message here and send it to us


Related News
Read More >>
2026 FCC Certification and Compliance 2026 FCC Certification and Compliance
03 .15.2026
AIoT growth makes FCC compliance critical for global sellers. Using FCC Part 15 and CE standards, JJ...
What are the requirements of UL 62368-1:2025? What are the requirements of UL 62368-1:2025?
03 .15.2026
UL 62368-1:2025 updates AV/ICT safety: new component certification, coin-cell protection, power limi...
Electric Bicycle Certification in New South Wales, Electric Bicycle Certification in New South Wales,
03 .15.2026
NSW phases e-bike and e-scooter battery rules: Feb 2025 meet AS/EN/UL standards; Aug 2025 approval r...
What is the European Accessibility Act (EAA)? What is the European Accessibility Act (EAA)?
03 .14.2026
What is the European Accessibility Act (EAA)? : EU law from 28 June 2025 requiring digital products ...
Compliance Guidelines for India IS/IEC 62368-1:202 Compliance Guidelines for India IS/IEC 62368-1:202
03 .14.2026
ndia Compliance Guidelines for IS/IEC 62368-1:2023 replace IS13252-1 and IS616 and include XR device...
16 CFR Part 1512 Compliance Testing Laboratory 16 CFR Part 1512 Compliance Testing Laboratory
03 .13.2026
US bicycle market entry requires 16 CFR Part 1512 compliance. JJR Lab, CPSC-accredited, provides tes...
Electromagnetic Compatibility and Interference Tes Electromagnetic Compatibility and Interference Tes
03 .13.2026
EMC testing ensures devices work without interference by checking EMI emissions and EMS immunity und...
What is 21 CFR Part 11 Compliance and Regulations What is 21 CFR Part 11 Compliance and Regulations
03 .13.2026
21 CFR Part 11 is an FDA rule defining how electronic records and e-signatures must be managed so th...

Leave Your Message